Search Results 531-540 of 21459 for anti-TNF drugs

1. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

2. Zinc - Mayo Clinic

   People use oral zinc to help treat colds, but it can decrease the effectiveness of certain drugs and cause side effects. ... These blood pressure drugs increase ...

3. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

4. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

5. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

   Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

6. Thrombin Human, Recombinant (Topical Application Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Recothrom. Canadian Brand Name. Thrombinar ...

7. Duloxetine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Some pain medicines may increase heart attack risk after surgery - Mayo Clinic News Network

   In a McGill University study published recently in the British Medical Journal, researchers found that post-surgery use of nonsteroidal anti-inflammatory drugs ...

9. Alzheimer's drug lecanemab granted full approval by FDA, Mayo Clinic expert weighs in

   The Food and Drug Administration (FDA) granted traditional approval of a disease-modifying treatment that could potentially give some patients with ...

10. Cough And Cold Combinations (Oral Route) Description and Brand Names - Mayo Clinic

    The main expectorant used in cough and cold medicines is guaifenesin. Other ingredients added as expectorants (for example, ammonium chloride, calcium iodide, ...